Rare diseases
Investigational molecules
Locations
Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer
FinlandEffect of botulinum toxin type A - haemagglutinin complex on refractory upper‑limb resting tremor in Parkinson disease patients (drug‑combination study)
FranceSafety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study
DenmarkCarboplatin drug combination as neoadjuvant therapy for early stage II triple‑negative breast cancer
FranceStudy of BIIB115 in patients aged 15‑60 years with spinal muscular atrophy who are treatment‑naïve or previously treated with risdiplam
FinlandPhase II Study of 99mTc NTP15-5 Imaging to Detect Hand Joint Disease in Patients with Rheumatoid Arthritis and Finger Osteoarthritis
FranceTeclistamab drug combination versus daratumumab and lenalidomide in MRD‑positive multiple myeloma patients after stem cell transplant
PolandRandomized Study of SIR9900 for Safety and Effectiveness in Patients with VEXAS Syndrome
ItalyStudy of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels
AustriaStudy of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab
ItalyPhase 2/3 Randomized Study of SKY-0515 for Safety and Efficacy in Adults with Huntington’s Disease
GermanyEffect of liraglutide on immune response to pneumococcal polysaccharide vaccine in adults with diabetes
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
